- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Evercore ISI analyst Josh Schimmer is bullish on biotech.
Big gains could be ahead for investors willing to stick with the stock, according to one firm.
My three top predictions for the next six months.